Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat.

Literature DB >> 290

The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat.

B Isomaa, G Sjöblom.

Abstract

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 1975 PMID： 290 DOI： 10.1016/0015-6264(75)90005-x

Source DB: PubMed Journal: Food Cosmet Toxicol ISSN： 0015-6264

× No keyword cloud information.

11 in total

1. Parkinson disease at the end of life: caregiver perspectives.

Authors: Elizabeth R Goy; Julie H Carter; Linda Ganzini
Journal: Neurology Date: 2007-08-07 Impact factor: 9.910

2. Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative care.

Authors: Lynne Turner-Stokes; Nigel Sykes; Eli Silber
Journal: Clin Med (Lond) Date: 2008-04 Impact factor: 2.659

3. Rivastigmine for dementia associated with Parkinson's disease.

Authors: Murat Emre; Dag Aarsland; Alberto Albanese; E Jane Byrne; Günther Deuschl; Peter P De Deyn; Franck Durif; Jaime Kulisevsky; Teus van Laar; Andrew Lees; Werner Poewe; Alain Robillard; Mario M Rosa; Erik Wolters; Peter Quarg; Sibel Tekin; Roger Lane
Journal: N Engl J Med Date: 2004-12-09 Impact factor: 91.245

4. Severity of chronic pain and its relationship to quality of life in multiple sclerosis.

Authors: Lorraine V Kalia; Paul W O'Connor
Journal: Mult Scler Date: 2005-06 Impact factor: 6.312

5. A survey of pain in idiopathic Parkinson's disease.

Authors: Mark A Lee; Richard W Walker; Tony J Hildreth; Wendy M Prentice
Journal: J Pain Symptom Manage Date: 2006-11 Impact factor: 3.612

Review 6. Cognitive dysfunction in multiple sclerosis: a review of recent developments.

Authors: Julie A Bobholz; Stephen M Rao
Journal: Curr Opin Neurol Date: 2003-06 Impact factor: 5.710

7. A controlled trial of antidepressants in patients with Parkinson disease and depression.

Authors: M Menza; R D Dobkin; H Marin; M H Mark; M Gara; S Buyske; K Bienfait; A Dicke
Journal: Neurology Date: 2008-12-17 Impact factor: 9.910

Review 8. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors: Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal: Mov Disord Date: 2007-12 Impact factor: 10.338

The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat.

1. Parkinson disease at the end of life: caregiver perspectives.

2. Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative care.

3. Rivastigmine for dementia associated with Parkinson's disease.

4. Severity of chronic pain and its relationship to quality of life in multiple sclerosis.

5. A survey of pain in idiopathic Parkinson's disease.

Review 6. Cognitive dysfunction in multiple sclerosis: a review of recent developments.

7. A controlled trial of antidepressants in patients with Parkinson disease and depression.

Review 8. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Review 9. Parkinson's disease, palliative care and older people: Part 1.

10. Symptom prevalence and severity in people severely affected by multiple sclerosis.

1. The subacute and chronic toxicity of cetyltrimethylammonium bromide (CTAB), a cationic surfactant, in the rat.

2. Effect of surfactants on weight gain in mice.